DE9400863U1 - Anti-osteoporotic mixture - Google Patents

Anti-osteoporotic mixture

Info

Publication number
DE9400863U1
DE9400863U1 DE9400863U DE9400863U DE9400863U1 DE 9400863 U1 DE9400863 U1 DE 9400863U1 DE 9400863 U DE9400863 U DE 9400863U DE 9400863 U DE9400863 U DE 9400863U DE 9400863 U1 DE9400863 U1 DE 9400863U1
Authority
DE
Germany
Prior art keywords
vitamin
dose
proline
amino acids
antiosteoporotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE9400863U
Other languages
German (de)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kuebler Dr GmbH
Original Assignee
Kuebler Dr GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kuebler Dr GmbH filed Critical Kuebler Dr GmbH
Priority to DE9400863U priority Critical patent/DE9400863U1/en
Publication of DE9400863U1 publication Critical patent/DE9400863U1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Description

Antiosteoporotische Mischung enthaltend Flavone oder u Flayonoide, Vitamin C oder Ascorbinsäure, die Aminosäuren Lysin, Prolin, die Mineralsalze Kalzium und/oder Magnesium mit und ohne Vitamin D, mit und ohne Phosphor zur Stabilisierung des Knochenstoffwechsels als NahrungsmittelzusatzAntiosteoporotic mixture containing flavones or flayonoids , vitamin C or ascorbic acid, the amino acids lysine, proline, the mineral salts calcium and/or magnesium with and without vitamin D, with and without phosphorus for the stabilization of bone metabolism as a food supplement

Hintergrund:Background:

Die bisher üblichen, den Knochenstoffwechsel prophylaktisch oder therapeutisch angehenden Nahrungsmittelzusätze berücksichtigen lediglich die anorganischen Stoffe, die in der Nahrung fur den Knochen wichtig sind. Die physiologischen Bedingungen des Knochenstoffwechsels sind jedoch komplexer. So hat es sich gezeigt, da der Knochen, um überhaupt fähig zu sein, angebotene Minerale stabilisierend aufzunehmen, dazu eines aus Aminosäuren bestehenden Fasergerustes bedarf, welches er aus essentiellen Stoffen aufbauen mu . Dies sind Stoffe, die er sich nicht selbst herstellen kann. Im einzelnen:The usual food supplements that have been used to prevent or treat bone metabolism only take into account the inorganic substances in food that are important for bones. However, the physiological conditions of bone metabolism are more complex. It has been shown that in order to be able to absorb minerals in a stabilizing manner, bones need a fiber structure made up of amino acids, which they must build up from essential substances. These are substances that they cannot produce themselves. In detail:

Die essentielle Aminosäure Lysin, die Aminosäure Prolin, das Vitamin C oder die Ascorbinsäure. In der Natur kommt das Vitamin C so gut wie immer in der pflanzlichen Nahrung in Kombination mit Flavonen und/oder Flavonoiden vor. Unter der Anregung von katalytisch wirksamen Peptiden, denen eine Hormonwirkung zugesprochen wird, wie dem Kalzitonin, fangt sich die organische Matrix des Knochens die folgenden Minerale ein: Kalzium, Magnesium, Phosphate, die Spurenelemente Silicium, Fluor und Kupfer. Davon ausgehend wird eine geeignete Mischung vorgestellt, enthaltend:The essential amino acid lysine, the amino acid proline, vitamin C or ascorbic acid. In nature, vitamin C is almost always found in plant foods in combination with flavones and/or flavonoids. Under the stimulation of catalytically active peptides, which are said to have a hormonal effect, such as calcitonin, the organic matrix of the bone captures the following minerals: calcium, magnesium, phosphates, the trace elements silicon, fluorine and copper. Based on this, a suitable mixture is presented, containing:

10 - 1000 mg Flavone, im Durchschnitt 200 mg 10 - 1000 mg Vitamin C,/im Durchschnitt 100 mg10 - 1000 mg flavones, on average 200 mg 10 - 1000 mg vitamin C, / on average 100 mg

10 - 1000 mg der Aminosäuren Lysin und Prolin, im Durchschnitt 100 mg10 - 1000 mg of the amino acids lysine and proline, on average 100 mg

10 - 1000 mg der.Minerale Kalzium oder Magnesium, im Durchschnitt 200 mg10 - 1000 mg of the minerals calcium or magnesium, on average 200 mg

Aus resorptiven Gründen enthalt das Präparat niemals gemeinsam Kalzium und Magnesium, sondern es gibt es in einer kalzium- und einer magnesiumhaltigen Version. Beide Versionen können die knochenrelevanten Spurenelemente Kupfer, Silicium und Fluor in homoeopatlscher Dosis enthalten.For absorption reasons, the preparation never contains calcium and magnesium together, but is available in a calcium and a magnesium-containing version. Both versions can contain the bone-relevant trace elements copper, silicon and fluorine in homoeopathic doses.

Claims (7)

Ansprueche:Expectations: 1) Antiosteoporotische Mischung enthaltend Flavone oder Flavonoide in einer Dosis von 10-lOOOmg, vorzugsweise 200mg, Vitamin C oder Ascorbinsäure, 10-lOOOmg, vorzugsweise 100mg, die Aminosäuren Lysin, Prolin, je 10-500mg, vorzugsweise 100mg, das Mineralsalz Kalzium, in einer Dosis von 10-lOOmg, vorzugsweise 200mg, Vitamin D3 ,50-10 000 I.E., vorzugsweise 500 I.E., zur Stabilisierung des Knochenstoffwechsels als Nahrungsmittelzusatz.1) Antiosteoporotic mixture containing flavones or flavonoids in a dose of 10-1000mg, preferably 200mg, vitamin C or ascorbic acid, 10-1000mg, preferably 100mg, the amino acids lysine, proline, 10-500mg each, preferably 100mg, the mineral salt calcium, in a dose of 10-1000mg, preferably 200mg, vitamin D3, 50-10,000 IU, preferably 500 IU, for stabilizing bone metabolism as a food supplement. 2) Antiosteoporotische Mischung enthaltend Flavone oder Flavonoide in einer Dosis von 10-lOOOmg, vorzugsweise 200mg, Vitamin C oder Ascorbinsäure, 10-lOOOmg, vorzugsweise 100mg, die Aminosäuren Lysin, Prolin, je 10-500mg, vorzugsweise 100mg, das Mineralsalz Magnesium, in einer Dosis von 10-100mg, vorzugsweise 300mg, Vitamin D3 ,50-10 000 I.E., vorzugsweise 500 I.E., zur Stabilisierung des Knochenstoffwechsels als Nahrungsmittelzusatz.2) Antiosteoporotic mixture containing flavones or flavonoids in a dose of 10-1000mg, preferably 200mg, vitamin C or ascorbic acid, 10-1000mg, preferably 100mg, the amino acids lysine, proline, 10-500mg each, preferably 100mg, the mineral salt magnesium, in a dose of 10-100mg, preferably 300mg, vitamin D3, 50-10,000 IU, preferably 500 IU, for stabilizing bone metabolism as a food supplement. 3) Antiosteoporotische Mischung enthaltend Flavone oder Flavonoide in einer Dosis von 10-lOOOmg, vorzugsweise 200mg, Vitamin C oder Ascorbinsäure, 10-lOOOmg, vorzugsweise 100mg, die Aminosäuren Lysin, Prolin, je l0-500mg, vorzugsweise 100mg, das Mineralsalz Kalzium, in einer Dosis von 10-lOOmg, vorzugsweise 200mg, zur Stabilisierung des Knochenstoffwechsels als Nahrungsmittelzusatz.3) Antiosteoporotic mixture containing flavones or flavonoids in a dose of 10-1000mg, preferably 200mg, vitamin C or ascorbic acid, 10-1000mg, preferably 100mg, the amino acids lysine, proline, each 10-500mg, preferably 100mg, the mineral salt calcium, in a dose of 10-100mg, preferably 200mg, for stabilizing bone metabolism as a food additive. 4) Antiosteoporotische Mischung enthaltend Flavone oder Flavonoide in einer Dosis von 10-lOOOmg, vorzugsweise 200mg, Vitamin C oder Ascorbinsäure, 10-lOOOmg, vorzugsweise 100mg, die Aminosäuren Lysin, Prolin, je 10-500mg, vorzugsweise 100mg, das Mineralsalz Magnesium, in einer Dosis von 10-100mg, vorzugsweise 200mg, zur Stabilisierung des Knochenstoffwechsels als Nahrungsmittelzusatz.4) Antiosteoporotic mixture containing flavones or flavonoids in a dose of 10-1000mg, preferably 200mg, vitamin C or ascorbic acid, 10-1000mg, preferably 100mg, the amino acids lysine, proline, each 10-500mg, preferably 100mg, the mineral salt magnesium, in a dose of 10-100mg, preferably 200mg, for stabilizing bone metabolism as a food supplement. 5) Antiosteoporotische Mischung enthaltend Flavone oder Flavonoide in einer Dosis von 10-lOOOmg, vorzugsweise 200mg, Vitamin C oder Ascorbinsäure, 10-lOOOmg, vorzugsweise 100mg, die Aminosäuren Lysin, Prolin, je 10-500mg, vorzugsweise 100mg, das Mineralsalz Kalzium, in einer Dosis von 10-lOOmg, vorzugsweise 200mg, Vitamin D3 , 50-10 000 I.E., vorzugsweise 500 I.E., zur Stabilisierung des Knochenstoffwechsels als Nahrungsmittelzusatz.5) Antiosteoporotic mixture containing flavones or flavonoids in a dose of 10-1000mg, preferably 200mg, vitamin C or ascorbic acid, 10-1000mg, preferably 100mg, the amino acids lysine, proline, 10-500mg each, preferably 100mg, the mineral salt calcium, in a dose of 10-1000mg, preferably 200mg, vitamin D3, 50-10,000 IU, preferably 500 IU, for stabilizing bone metabolism as a food supplement. 6) Antiosteoporotische Mischung enthaltend Flavone oder Flavonoide in einer Dosis von 10-lOOOmg, vorzugsweise 200mg, Vitamin C oder Ascorbinsäure, 10-lOOOmg, vorzugsweise 100mg, die Aminosäuren Lysin, Prolin, je 10-500mg, vorzugsweise 100mg, das Kai&zgr;iumhydrogenphosphat, 10 -500mg, vorzugsweise6) Antiosteoporotic mixture containing flavones or flavonoids in a dose of 10-1000mg, preferably 200mg, vitamin C or ascorbic acid, 10-1000mg, preferably 100mg, the amino acids lysine, proline, each 10-500mg, preferably 100mg, the potassium hydrogen phosphate, 10-500mg, preferably 250mg, Vitamin D3 , SOflcTooCi^E^ 'voKzVl&sweise 500 I.E., zur Stabilisierung des knochenstoffwechsels als Nahrungsmittelzusatz.250mg, Vitamin D3, preferably 500 IU, to stabilize bone metabolism as a food supplement. 7) Antiosteoporotische Mischung enthaltend Flavone oder Flavonoide in einer Dosis von 10-lOOOmg, vorzugsweise 200mg, Vitamin C oder Ascorbinsäure, 10-lOOOmg, vorzugsweise 100mg, die Aminosäuren Lysin, Prolin, je 10-500mg, vorzugsweise 100mg, das Magnesiumhydrogenphosphat, 10-500mg, vorzugsweise 50mg, Vitamin D3 , 50-10 000 I.E., vorzugsweise 500 I.E., zur Stabilisierung des Knochenstoffwechsels als Nahrungsmittelzusatz.7) Antiosteoporotic mixture containing flavones or flavonoids in a dose of 10-1000mg, preferably 200mg, vitamin C or ascorbic acid, 10-1000mg, preferably 100mg, the amino acids lysine, proline, each 10-500mg, preferably 100mg, magnesium hydrogen phosphate, 10-500mg, preferably 50mg, vitamin D3, 50-10,000 IU, preferably 500 IU, for stabilizing bone metabolism as a food supplement.
DE9400863U 1994-01-19 1994-01-19 Anti-osteoporotic mixture Expired - Lifetime DE9400863U1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE9400863U DE9400863U1 (en) 1994-01-19 1994-01-19 Anti-osteoporotic mixture

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE9400863U DE9400863U1 (en) 1994-01-19 1994-01-19 Anti-osteoporotic mixture

Publications (1)

Publication Number Publication Date
DE9400863U1 true DE9400863U1 (en) 1994-04-14

Family

ID=6903420

Family Applications (1)

Application Number Title Priority Date Filing Date
DE9400863U Expired - Lifetime DE9400863U1 (en) 1994-01-19 1994-01-19 Anti-osteoporotic mixture

Country Status (1)

Country Link
DE (1) DE9400863U1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1340428A2 (en) * 1997-11-24 2003-09-03 Bristol-Myers Squibb Company Fortified confectionery and methods of preparation thereof
US7655264B2 (en) 1997-08-29 2010-02-02 Mcneil-Ppc, Inc. Process for promoting calcium absorption

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7655264B2 (en) 1997-08-29 2010-02-02 Mcneil-Ppc, Inc. Process for promoting calcium absorption
EP1340428A2 (en) * 1997-11-24 2003-09-03 Bristol-Myers Squibb Company Fortified confectionery and methods of preparation thereof
EP1340428A3 (en) * 1997-11-24 2005-03-02 Bristol-Myers Squibb Company Fortified confectionery and methods of preparation thereof

Similar Documents

Publication Publication Date Title
DE3752112T2 (en) Use of inositol triphosphate to treat inflammation
DE693928T1 (en) AMINO SUGAR AND GLYCOSAMINOGLYCAN COMPOSITION FOR THE TREATMENT AND REPAIR OF FABRIC TISSUE
CN108308493A (en) A kind of anti-fatigue solid beverage and preparation method of astaxanthin-containing
US5612061A (en) Composition and method for the treatment of premenstrual syndrome
DE9400863U1 (en) Anti-osteoporotic mixture
DE1935879A1 (en) Pharmaceutical preparation and process for the manufacture thereof
GB2231794B (en) Method for treating and preventing loss of bone mass
DE60124516T3 (en) COMBINATION OF THE LEZITHINE WITH ASCORBIC ACID
WO2018178146A1 (en) Physiologically active preparation comprising n-acetyl-glucosamine for the treatment of back pain
JP2561116B2 (en) Hair restorer
WO1994023689A1 (en) Hair growth promoting preparation
DE29709820U1 (en) Special food additive
EP0426098B1 (en) Phosphate binding agent for oral administration
DE2523394A1 (en) PHARMACEUTICAL PREPARATION
EP0051789A2 (en) Composition for activating hair grooth
CN105124702B (en) It is a kind of suitable for the replenishers of menstruating women or beverage and preparation method thereof
CN1050035C (en) Method for producing nutritive health-care honey
WO2007031291A2 (en) Foodstuff additive
EP0920321A1 (en) Vitamine preparations for reducing oxygen consumption during physical efforts
EP1228706A1 (en) Composition for enhancing the forming of connective tissue and for conditioning the body for high physical performance
WO1997038701A1 (en) Composition and method for the treatment of premenstrual syndrome
DE3826903A1 (en) Edible salt from ground rock salt or crystallised evaporated salt
DE19720818A1 (en) Composition enhancing sports performance
DE602004002718T2 (en) Pharmaceutical compositions for the treatment of herpes zoster
DE9110794U1 (en) Means for the prophylaxis of alcohol damage